<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">34249668</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">2231-3796</ISSN><JournalIssue CitedMedium="Print"><Volume>74</Volume><Issue>Suppl 3</Issue><PubDate><Year>2022</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India</Title><ISOAbbreviation>Indian J Otolaryngol Head Neck Surg</ISOAbbreviation></Journal><ArticleTitle>Post Viral Olfactory Dysfunction After SARS-CoV-2 Infection: Anticipated Post-pandemic Clinical Challenge.</ArticleTitle><Pagination><StartPage>4571</StartPage><EndPage>4578</EndPage><MedlinePgn>4571-4578</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12070-021-02730-6</ELocationID><Abstract><AbstractText>Persistent olfactory dysfunction (OD) is the second most common symptom of post coronavirus disease-19 (COVID-19) now being termed long-COVID. Its prevalence after recovery from COVID-19 is estimated to be 12% after nearly 6&#xa0;months of follow-up. It thus becomes imperative for the treating clinicians to update themselves with the pathophysiology of this post COVID disability as well as the tools for diagnosis and the available treatment options. A systematic literature search was performed as per PRISMA guidelines in MEDLINE, Cochrane Library, LILACS, Google Scholar, <i>ClinicalTrials.gov,</i> and medRxiv databases. The keywords used were <i>covid-19</i>, <i>Olfactory Disorders</i>, <i>Smell, Anosmia</i>, <i>PVOD</i>, <i>Post Viral Olfactory Disorders</i>, <i>post-covid</i> and <i>post haul</i>. All articles were studied for definition, mechanism, diagnostic tests and treatment options for post COVID OD. 33 published articles and 8 ongoing trials were found relevant and included after full-text review. SARS-CoV-2 can cause conductive, neural and central OD. Olfactory evaluation can be done both subjectively (visual analogue scale) and objectively (Sniffin' sticks, Sinonasal Outcome Test, University of Pennsylvania Smell Identification Test and modified Davidson's alcohol sniff test). They can be used to detect and follow-up patients. Despite several on-going clinical trials, the most reliable and advisable treatment option available till date is olfactory training.</AbstractText><CopyrightInformation>&#xa9; Association of Otolaryngologists of India 2021.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kapoor</LastName><ForeName>Dhruv</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-9151-2786</Identifier><AffiliationInfo><Affiliation>Department of Otorhinolaryngology, University College of Medical Sciences, Delhi, India.</Affiliation><Identifier Source="GRID">grid.412444.3</Identifier><Identifier Source="ISNI">0000 0004 1806 781X</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verma</LastName><ForeName>Neha</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Otorhinolaryngology, University College of Medical Sciences, Delhi, India.</Affiliation><Identifier Source="GRID">grid.412444.3</Identifier><Identifier Source="ISNI">0000 0004 1806 781X</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>Present Address: Department of Otorhinolaryngology, Guru Teg Bahadur Hospital, Ward 25, Delhi, 110 095 India.</Affiliation><Identifier Source="GRID">grid.413343.2</Identifier><Identifier Source="ISNI">0000 0004 1767 6592</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gupta</LastName><ForeName>Neelima</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Otorhinolaryngology, University College of Medical Sciences, Delhi, India.</Affiliation><Identifier Source="GRID">grid.412444.3</Identifier><Identifier Source="ISNI">0000 0004 1806 781X</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goyal</LastName><ForeName>Arun</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Otorhinolaryngology, University College of Medical Sciences, Delhi, India.</Affiliation><Identifier Source="GRID">grid.412444.3</Identifier><Identifier Source="ISNI">0000 0004 1806 781X</Identifier></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>07</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>India</Country><MedlineTA>Indian J Otolaryngol Head Neck Surg</MedlineTA><NlmUniqueID>9422551</NlmUniqueID><ISSNLinking>2231-3796</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Anosmia</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Long-COVID</Keyword><Keyword MajorTopicYN="N">Olfaction disorders</Keyword><Keyword MajorTopicYN="N">PVOD</Keyword><Keyword MajorTopicYN="N">Post COVID</Keyword><Keyword MajorTopicYN="N">Post viral</Keyword></KeywordList><CoiStatement>Conflict of interestNone of the authors have any competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>5</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>6</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>7</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>13</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>7</Month><Day>12</Day><Hour>5</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>12</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34249668</ArticleId><ArticleId IdType="pmc">PMC8260324</ArticleId><ArticleId IdType="doi">10.1007/s12070-021-02730-6</ArticleId><ArticleId IdType="pii">2730</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Stavem K, Ghanima W, Olsen MK, Gilboe HM, Einvik G (2020) Persistent symptoms 1.5&#x2013;6 months after COVID-19 in non-hospitalised subjects: a population-based cohort study. Thorax [Internet]. 2020 Dec 3 [cited 2020 Dec 19]; thoraxjnl-2020-216377. https://www.thorax.bmj.com/lookup/doi/10.1136/thoraxjnl-2020-216377</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7716295</ArticleId><ArticleId IdType="pubmed">33273028</ArticleId></ArticleIdList></Reference><Reference><Citation>Kosugi EM, Lavinsky J, Romano FR, Fornazieri MA, Luz-Matsumoto GR, Lessa MM et al (2020) Incomplete and late recovery of sudden olfactory dysfunction in COVID-19. Braz J Otorhinolaryngol [Internet]. 2020 [cited 2020 Dec 19]; 86(4):490&#x2013;496. https://pubmed.ncbi.nlm.nih.gov/32534982/</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7247498</ArticleId><ArticleId IdType="pubmed">32534982</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfizer, Oxford COVID-19 vaccines reduces severity of the disease in elderly: pre-print study - Health News, Firstpost [Internet]. [cited 2021 Mar 3]. https://www.firstpost.com/health/pfizer-oxford-covid-19-vaccines-reduces-severity-of-the-disease-in-elderly-pre-print-study-9369331.html</Citation></Reference><Reference><Citation>Hajikhani B, Calcagno T, Nasiri MJ, Jamshidi P, Dadashi M, Goudarzi M et al (2020) Olfactory and gustatory dysfunction in COVID-19 patients: a meta-analysis study. Physiol Rep [Internet]. 2020 Sep [cited 2020 Dec 15]; 8(18):e14814. https://pubmed.ncbi.nlm.nih.gov/32975884/</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7518296</ArticleId><ArticleId IdType="pubmed">32975884</ArticleId></ArticleIdList></Reference><Reference><Citation>Von Bartheld CS, Butowt R, Hagen MM (2020) Prevalence of chemosensory dysfunction in COVID-19 patients: a systematic review and meta-analysis reveals significant ethnic differences. ACS Chem Neurosci [Internet]. 2020 Oct 7 [cited 2020 Dec 15]; 11(19):2944&#x2013;2961. https://pubmed.ncbi.nlm.nih.gov/32870641/</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7571048</ArticleId><ArticleId IdType="pubmed">32870641</ArticleId></ArticleIdList></Reference><Reference><Citation>Somekh I, Yakub Hanna H, Heller E, Bibi H, Somekh E (2020) Age-dependent sensory impairment in COVID-19 infection and its correlation with ACE2 expression. Pediatr Infect Dis J [Internet]. 2020 Sep [cited 2020 Dec 17]; 39(9):e270&#x2013;e272. https://pubmed.ncbi.nlm.nih.gov/32658093/</Citation><ArticleIdList><ArticleId IdType="pubmed">32658093</ArticleId></ArticleIdList></Reference><Reference><Citation>Otte MS, Klussmann JP, Luers JC (2020) Persisting olfactory dysfunction in patients after recovering from COVID-19. J Infect [Internet]. 2020 Sep [cited 2020 Dec 22]; 81(3):e58. https://pesquisa.bvsalud.org/portal/resource/en/mdl-32592702</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7313498</ArticleId><ArticleId IdType="pubmed">32592702</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaira LA, Hopkins C, Petrocelli M, Lechien JR, Chiesa-Estomba CM, Salzano G et al (2020) Smell and taste recovery in coronavirus disease 2019 patients: a 60-day objective and prospective study. J Laryngol Otol [Internet]. 2020 Aug [cited 2020 Dec 19]; 134(8):703&#x2013;709. https://www.cambridge.org/core/product/identifier/S0022215120001826/type/journal_article</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7471571</ArticleId><ArticleId IdType="pubmed">32782030</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechien JR, Michel J, Radulesco T, Chiesa-Estomba CM, Vaira LA, De Riu G et al (2020) Clinical and radiological evaluations of COVID-19 patients with anosmia: preliminary report. Laryngoscope [Internet]. 2020 Nov [cited 2021 Jan 2]; 130(11):2526&#x2013;2531. https://pubmed.ncbi.nlm.nih.gov/32678494/</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7404961</ArticleId><ArticleId IdType="pubmed">32678494</ArticleId></ArticleIdList></Reference><Reference><Citation>Eliezer M, Hamel A-L, Houdart E, Herman P, Housset J, Jourdaine C et al (2020) Loss of smell in COVID-19 patients: MRI data reveals a transient edema of the olfactory clefts. Neurology [Internet]. 2020 Dec 8 [cited 2020 Dec 17]; 95(23):e3145&#x2013;e3152. https://pubmed.ncbi.nlm.nih.gov/32917809/</Citation><ArticleIdList><ArticleId IdType="pubmed">32917809</ArticleId></ArticleIdList></Reference><Reference><Citation>Kandemirli SG, Altundag A, Yildirim D, Tekcan Sanli DE, Saatci O (2021) Olfactory bulb MRI and paranasal sinus CT findings in persistent COVID-19 anosmia. Acad Radiol [Internet]. 2021 Jan [cited 2020 Dec 15]; 28(1):28&#x2013;35. https://pubmed.ncbi.nlm.nih.gov/33132007/</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7571972</ArticleId><ArticleId IdType="pubmed">33132007</ArticleId></ArticleIdList></Reference><Reference><Citation>Brann DH, Tsukahara T, Weinreb C, Lipovsek M, Van Den Berge K, Gong B et al (2020) Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia. Sci Adv [Internet]. 2020 Jul 31 [cited 2020 Dec 22]; 6(31). https://pesquisa.bvsalud.org/portal/resource/en/mdl-32937591</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10715684</ArticleId><ArticleId IdType="pubmed">32937591</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilinska K, Jakubowska P, Von Bartheld CS, Butowt R (2020) Expression of the SARS-CoV-2 entry proteins, ACE2 and TMPRSS2, in cells of the olfactory epithelium: identification of cell types and trends with age. ACS Chem Neurosci [Internet]. 2020 Jun 3 [cited 2020 Dec 22]; 11(11):1555&#x2013;1562. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7241737/</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7241737</ArticleId><ArticleId IdType="pubmed">32379417</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen M, Shen W, Rowan NR, Kulaga H, Hillel A, Ramanathan M et al (2020) Elevated ACE-2 expression in the olfactory neuroepithelium: implications for anosmia and upper respiratory SARS-CoV-2 entry and replication. Eur Respir J [Internet]. 2020 Sep 24 [cited 2020 Dec 15]; 56(3):2001948. https://pubmed.ncbi.nlm.nih.gov/32817004/</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7439429</ArticleId><ArticleId IdType="pubmed">32817004</ArticleId></ArticleIdList></Reference><Reference><Citation>Torabi A, Mohammadbagheri E, Akbari Dilmaghani N, Bayat AH, Fathi M, Vakili K et al (2020) Proinflammatory cytokines in the olfactory mucosa result in COVID-19 induced anosmia. ACS Chem Neurosci [Internet]. 2020 Jul 1 [cited 2020 Dec 22]; 11(13):1909&#x2013;1913. https://pesquisa.bvsalud.org/portal/resource/en/mdl-32525657</Citation><ArticleIdList><ArticleId IdType="pubmed">32525657</ArticleId></ArticleIdList></Reference><Reference><Citation>Lane AP, Turner J, May L, Reed R (2010) A genetic model of chronic rhinosinusitis-associated olfactory inflammation reveals reversible functional impairment and dramatic neuroepithelial reorganization. J Neurosci [Internet]. 2010 Feb 10 [cited 2020 Dec 25]; 30(6):2324&#x2013;2329. https://www.jneurosci.org/content/30/6/2324</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2957830</ArticleId><ArticleId IdType="pubmed">20147558</ArticleId></ArticleIdList></Reference><Reference><Citation>Netland J, Meyerholz DK, Moore S, Cassell M, Perlman S (2008) Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J Virol [Internet]. 2008 Aug [cited 2020 Dec 27]; 82(15):7264&#x2013;7275. https://pubmed.ncbi.nlm.nih.gov/18495771/</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2493326</ArticleId><ArticleId IdType="pubmed">18495771</ArticleId></ArticleIdList></Reference><Reference><Citation>Daly JL, Simonetti B, Klein K, Chen KE, Williamson MK, Ant&#xf3;n-Pl&#xe1;garo C et al (2020) Neuropilin-1 is a host factor for SARS-CoV-2 infection. Science [Internet]. 2020 Nov 13 [cited 2021 Jan 2]; 370(6518):861&#x2013;865. https://pubmed.ncbi.nlm.nih.gov/33082294/</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7612957</ArticleId><ArticleId IdType="pubmed">33082294</ArticleId></ArticleIdList></Reference><Reference><Citation>Cantuti-Castelvetri L, Ojha R, Pedro LD, Djannatian M, Franz J, Kuivanen S et al (2020) Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity. Science (80- ) [Internet]. 2020 Nov 13 [cited 2021 Jan 2]; 370(6518):856&#x2013;860. https://pubmed.ncbi.nlm.nih.gov/33082293/</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7857391</ArticleId><ArticleId IdType="pubmed">33082293</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawakami A, Kitsukawa T, Takagi S, Fujisawa H (1996) Developmentally regulated expression of a cell surface protein, neuropilin, in the mouse nervous system. J Neurobiol [Internet]. 1996 Jan [cited 2021 Jan 3]; 29(1):1&#x2013;17. https://pubmed.ncbi.nlm.nih.gov/8748368/</Citation><ArticleIdList><ArticleId IdType="pubmed">8748368</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies J, Randeva HS, Chatha K, Hall M, Spandidos DA, Karteris E et al (2020) Neuropilin-1 as a new potential SARS-CoV-2 infection mediator implicated in the neurologic features and central nervous system involvement of COVID-19. Mol Med Rep [Internet]. 2020 Nov [cited 2021 Jan 2];2 2(5):4221&#x2013;4226. https://pubmed.ncbi.nlm.nih.gov/33000221/</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7533503</ArticleId><ArticleId IdType="pubmed">33000221</ArticleId></ArticleIdList></Reference><Reference><Citation>Han AY, Mukdad L, Long JL, Lopez IA (2020) Anosmia in COVID-19: mechanisms and significance [Internet]. Vol. 45, Chemical Senses. Oxford University Press; 2020 [cited 2020 Dec 19]. p. 423&#x2013;8. https://academic.oup.com/chemse/article/45/6/423/5859163</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7449368</ArticleId><ArticleId IdType="pubmed">32556089</ArticleId></ArticleIdList></Reference><Reference><Citation>Chee J, Wang DY (2021) Understanding COVID-19-related olfactory dysfunction. JAMA Otolaryngol&#x2014;Head Neck Surg [Internet]. 2020 Nov 19 [cited 2021 Feb 7]; 146(7):672&#x2013;674. http://www.biorxiv.org/content/10.1101/2020.03.25.009084v4</Citation><ArticleIdList><ArticleId IdType="pubmed">33211116</ArticleId></ArticleIdList></Reference><Reference><Citation>Calvo-Henriquez C, Maldonado-Alvarado B, Chiesa-Estomba C, Rivero-Fern&#xe1;ndez I, Sanz-Rodriguez M, Villarreal IM et al (2020) Ethyl alcohol threshold test: a fast, reliable and affordable olfactory Assessment tool for COVID-19 patients. Eur Arch Oto-Rhino-Laryngology [Internet]. 2020 Oct [cited 2020 Dec 19]; 277(10):2783&#x2013;2792. https://pubmed.ncbi.nlm.nih.gov/32583183/</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7312102</ArticleId><ArticleId IdType="pubmed">32583183</ArticleId></ArticleIdList></Reference><Reference><Citation>Moein ST, Hashemian SMR, Mansourafshar B, Khorram-Tousi A, Tabarsi P, Doty RL (2020) Smell dysfunction: a biomarker for COVID-19. Int Forum Allergy Rhinol [Internet]. 2020 Aug [cited 2020 Dec 18]; 10(8):944&#x2013;950. https://pubmed.ncbi.nlm.nih.gov/32301284/</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7262123</ArticleId><ArticleId IdType="pubmed">32301284</ArticleId></ArticleIdList></Reference><Reference><Citation>Otte MS, Eckel HNC, Poluschkin L, Klussmann JP, Luers JC (2020) Olfactory dysfunction in patients after recovering from COVID-19. Acta Otolaryngol [Internet]. 2020 Dec [cited 2020 Dec 17]; 140(12):1032&#x2013;1035. https://pubmed.ncbi.nlm.nih.gov/32852240/</Citation><ArticleIdList><ArticleId IdType="pubmed">32852240</ArticleId></ArticleIdList></Reference><Reference><Citation>da Costa KVT, Carna&#xfa;ba ATL, Rocha KW, de Andrade KCL, Ferreira SMS, Menezes PdeL (2020) Olfactory and taste disorders in COVID-19: a systematic review [Internet]. Vol. 86, Brazilian Journal of Otorhinolaryngology. Elsevier Editora Ltda; 2020 [cited 2020 Dec 22]. pp 781&#x2013;92. https://pubmed.ncbi.nlm.nih.gov/32580925/</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7280089</ArticleId><ArticleId IdType="pubmed">32580925</ArticleId></ArticleIdList></Reference><Reference><Citation>Hura N, Xie DX, Choby GW, Schlosser RJ, Orlov CP, Seal SM et al (2020) Treatment of post-viral olfactory dysfunction: an evidence-based review with recommendations [Internet]. Vol. 10, International Forum of Allergy and Rhinology. John Wiley and Sons Inc; 2020. pp 1065&#x2013;86. https://onlinelibrary.wiley.com/doi/full/10.1002/alr.22624</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7361320</ArticleId><ArticleId IdType="pubmed">32567798</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M, Kleine-Weber H, Schroeder S, Kr&#xfc;ger N, Herrler T, Erichsen S et al (2020) SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell [Internet]. 2020 Apr 16 [cited 2021 Jan 2]; 181(2):271&#x2013;280.e8. https://pubmed.ncbi.nlm.nih.gov/32142651/</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Vofo G, Brodie R, Gross M (2020) Nasal lavage containing Angiotensin-Converting Enzyme-2 agonist can prevent and reduce viral load in COVID-19. Med Hypotheses [Internet]. 2020 Nov [cited 2020 Dec 17]; 144:110207. https://pubmed.ncbi.nlm.nih.gov/33254514/</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7444481</ArticleId><ArticleId IdType="pubmed">33254514</ArticleId></ArticleIdList></Reference><Reference><Citation>Soler ZM, Patel ZM, Turner JH, Holbrook EH (2020) A primer on viral&#x2010;associated olfactory loss in the era of COVID&#x2010;19. Int Forum Allergy Rhinol [Internet]. 2020 Jul [cited 2021 Jan 3]; 10(7):814&#x2013;820. https://onlinelibrary.wiley.com/doi/abs/10.1002/alr.22578</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7262311</ArticleId><ArticleId IdType="pubmed">32271490</ArticleId></ArticleIdList></Reference><Reference><Citation>Kollndorfer K, Fischmeister FPS, Kowalczyk K, Hoche E, Mueller CA, Trattnig S et al (2015) Olfactory training induces changes in regional functional connectivity in patients with long-term smell loss. NeuroImage Clin [Internet]. 2015 Sep 15 [cited 2021 Jan 3]; 9:401&#x2013;410. https://pubmed.ncbi.nlm.nih.gov/26594622/</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4590718</ArticleId><ArticleId IdType="pubmed">26594622</ArticleId></ArticleIdList></Reference><Reference><Citation>Hummel T, Reden KRJ, H&#xe4;hner A, Weidenbecher M, H&#xfc;ttenbrink KB (2009) Effects of olfactory training in patients with olfactory loss. Laryngoscope [Internet]. 2009 Mar [cited 2021 Jan 29]; 119(3):496&#x2013;499. https://pubmed.ncbi.nlm.nih.gov/19235739/</Citation><ArticleIdList><ArticleId IdType="pubmed">19235739</ArticleId></ArticleIdList></Reference><Reference><Citation>Altundag A, Cayonu M, Kayabasoglu G, Salihoglu M, Tekeli H, Saglam O et al (2015) Modified olfactory training in patients with postinfectious olfactory loss. Laryngoscope [Internet]. 2015 Aug [cited 2021 Jan 29]; 125(8):1763&#x2013;1766. https://pubmed.ncbi.nlm.nih.gov/26031472/</Citation><ArticleIdList><ArticleId IdType="pubmed">26031472</ArticleId></ArticleIdList></Reference><Reference><Citation>Damm M, Pikart LK, Reimann H, Burkert S, G&#xf6;ktas &#xd6;, Haxel B et al (2014) Olfactory training is helpful in postinfectious olfactory loss: a randomized, controlled, multicenter study. Laryngoscope [Internet]. 2014 Apr [cited 2021 Mar 3]; 124(4):826&#x2013;31. https://pubmed.ncbi.nlm.nih.gov/23929687/</Citation><ArticleIdList><ArticleId IdType="pubmed">23929687</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>